Baricitinib

Overview

Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA).

Application

Products > Drug Discovery > Impurities > Anti-Inflammatory > Baricitinib and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-457382
• CAS No.: 1187594-09-7
• Molecular Formula: C16H17N7O2S
• Molecular Weight: 371.419
• Purity: >98%
• Storage: Store at -20 °C
• Solubility: Soluble in DMF, DMSO

Source

Original product source